GSA Capital Partners’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-42,808
Closed -$455K 2026
2024
Q2
$455K Buy
42,808
+25,471
+147% +$271K 0.03% 1025
2024
Q1
$153K Buy
+17,337
New +$141K 0.01% 1444
2016
Q4
Sell
-21,300
Closed -$88K 1973
2016
Q3
$88K Sell
21,300
-1,200
-5% -$5.28K ﹤0.01% 1709
2016
Q2
$113K Buy
22,500
+300
+1% +$1.42K 0.01% 1659
2016
Q1
$114K Buy
22,200
+1,600
+8% +$8.67K 0.01% 1569
2015
Q4
$133K Buy
+20,600
New +$136K 0.01% 1708

Other funds holding ULBI

GSA Capital Partners's ULBI Position: Q3 2024 in Review

GSA Capital Partners sold out of Ultralife (ULBI) in Q3 2024, closing a stake of 42,808 shares — an estimated $455K sold.

GSA Capital Partners first reported a position in ULBI in Q4 2015 and held it in 6 quarters. The position peaked at $455K in Q2 2024. 74 funds tracked by Wall St. Rank hold ULBI as of Q3 2024.

  • GSA Capital Partners reported no remaining Ultralife position as of Q3 2024 after selling out during the quarter.
  • GSA Capital Partners sold 42,808 Ultralife shares in Q3 2024, an estimated $455K.
  • GSA Capital Partners first reported a position in Ultralife in Q4 2015 and held it in 6 quarters.
  • GSA Capital Partners's Ultralife position peaked at $455K in Q2 2024.
  • 74 funds tracked by Wall St. Rank held Ultralife as of Q3 2024.

Based on GSA Capital Partners's 13F filing for Q3 2024, filed 5 Nov 2024.